Phototoxicity of a core-modified porphyrin and induction of apoptosis

Journal of Photochemistry and Photobiology B: Biology

Volumn 85, Issue 3, 2006, Pages 155-162

  You, Youngjae ^a   Gibson, Scott L ^b   Detty, Michael R ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Breast cancer; Core modified porphyrin; Photodynamic therapy

Indexed keywords

5 PHENYL 10,15 BIS(CARBOXYLATOMETHOXYPHENYL) 20 (2 THIENYL) 21,23 DITHIAPORPHYRIN; IY 69; PORPHYRIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL COUNT; CELL DEATH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIGHT EXPOSURE; NONHUMAN; PHOTODYNAMICS; PHOTOSENSITIZATION; PHOTOTOXICITY; PRIORITY JOURNAL; RAT; TIME;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICE; NECROSIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TUMOR CELLS, CULTURED;

RODENTIA;

EID: 33750026947     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2006.07.002     Document Type: Article

References (31)

1. Kato H. Photodynamic therapy for lung cancer - a review of 19 years' experience. J. Photochem. Photobiol. B 42 (1998) 96-99
2. Ost D. Photodynamic therapy in lung cancer. A review. Methods Mol. Med. 75 (2003) 507-526
3. Prosst R.L., Wolfsen H.C., and Gahlen J. Photodynamic therapy for esophageal diseases: a clinical update. Endoscopy 35 (2003) 1059-1068
4. Guillemin F., Feintrenie X., and Lignon D. [Photodynamic therapy of bronchogenic cancer]. Rev. Pneumol. Clin. 48 (1992) 111-114
5. Love D.E.B.W.G. Photodynamic therapy comes of age. IDrugs 3 (2000) 1487-1508
6. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., and Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 90 (1998) 889-905
7. Detty M.R., Gibson S.L., and Wagner S.J. Current clinical and preclinical photosensitizers for use in photodynamic therapy. J. Med. Chem. 47 (2004) 3897-3915
8. Detty M.R. Photosensitizers for the photodynamic therapy of cancer and other diseases. Expert Opin. Ther. Pat. 11 (2001) 1849-1860
9. Stilts C.E., Nelen M.I., Hilmey D.G., Davies S.R., Gollnick S.O., Oseroff A.R., Gibson S.L., Hilf R., and Detty M.R. Water-soluble, core-modified porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapy. J. Med. Chem. 43 (2000) 2403-2410
10. Hilmey D.G., Abe M., Nelen M.I., Stilts C.E., Baker G.A., Baker S.N., Bright F.V., Davies S.R., Gollnick S.O., Oseroff A.R., Gibson S.L., Hilf R., and Detty M.R. Water-soluble, core-modified porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapy. II. Effects of core heteroatoms and meso-substituents on biological activity. J. Med. Chem. 45 (2002) 449-461
11. You Y., Gibson S.L., Hilf R., Davies S.R., Oseroff A.R., Roy I., Ohulchanskyy T.Y., Bergey E.J., and Detty M.R. Water soluble, core-modified porphyrins. 3. Synthesis, photophysical properties, and in vitro studies of photosensitization, uptake, and localization with carboxylic acid-substituted derivatives. J. Med. Chem. 46 (2003) 3734-3747
12. You Y., Gibson S.L., Hilf R., Ohulchanskyy T.Y., and Detty M.R. Core-modified porphyrins. Part 4: Steric effects on photophysical and biological properties in vitro. Bioorg. Med. Chem. 13 (2005) 2235-2251
13. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
14. Dika Nguea H., Rihn B., Mahon D., Bernard J.L., De Reydellet A., and Le Faou A. Effects of various man-made mineral fibers on cell apoptosis and viability. Arch. Toxikol. 79 (2005) 487-492
15. Essmann F., Engels I.H., Totzke G., Schulze-Osthoff K., and Janicke R.U. Apoptosis resistance of MCF-7 breast carcinoma cells to ionizing radiation is independent of p53 and cell cycle control but caused by the lack of caspase-3 and a caffeine-inhibitable event. Cancer Res. 64 (2004) 7065-7072
16. Xue L.Y., Chiu S.M., and Oleinick N.L. Photodynamic therapy-induced death of MCF-7 human breast cancer cells: a role for caspase-3 in the late steps of apoptosis but not for the critical lethal event. Exp. Cell Res. 263 (2001) 145-155
17. Whitacre C.M., Satoh T.H., Xue L., Gordon N.H., and Oleinick N.L. Photodynamic therapy of human breast cancer xenografts lacking caspase-3. Cancer Lett. 179 (2002) 43-49
18. Gibson S.L., Havens J.J., Nguyen M.L., and Hilf R. Delta-aminolaevulinic acid-induced photodynamic therapy inhibits protoporphyrin IX biosynthesis and reduces subsequent treatment efficacy in vitro. Brit. J. Cancer 80 (1999) 998-1004
19. Niedre M., Patterson M.S., and Wilson B.C. Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo. Photochem. Photobiol. 75 (2002) 382-391
20. Frankfurt O.S., and Krishan A. Apoptosis enzyme-linked immunosorbent assay distinguishes anticancer drugs from toxic chemicals and predicts drug synergism. Chem. Biol. Interact. 145 (2003) 89-99
21. Frankfurt O.S., and Krishan A. Enzyme-linked immunosorbent assay (ELISA) for the specific detection of apoptotic cells and its application to rapid drug screening. J. Immunol. Methods 253 (2001) 133-144
22. Oleinick N.L., Morris R.L., and Belichenko I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem. Photobiol. Sci. 1 (2002) 1-21
23. Rancan F., Wiehe A., Nobel M., Senge M.O., Omari S.A., Bohm F., John M., and Roder B. Influence of substitutions on asymmetric dihydroxychlorins with regard to intracellular uptake, subcellular localization and photosensitization of Jurkat cells. J. Photochem. Photobiol. B 78 (2005) 17-28
24. Gupta S., Dwarakanath B.S., Muralidhar K., and Jain V. Role of apoptosis in photodynamic sensitivity of human tumour cell lines. Indian J. Exp. Biol. 41 (2003) 33-40
25. Tremblay J.F., Dussault S., Viau G., Gad F., Boushira M., and Bissonnette R. Photodynamic therapy with toluidine blue in Jurkat cells: cytotoxicity, subcellular localization and apoptosis induction. Photochem. Photobiol. Sci. 1 (2002) 852-856
26. Dellinger M. Apoptosis or necrosis following Photofrin photosensitization: influence of the incubation protocol. Photochem. Photobiol. 64 (1996) 182-187
27. Kessel D., and Luo Y. Photodynamic therapy: a mitochondrial inducer of apoptosis. Cell Death Differ. 6 (1999) 28-35
28. Teiten M.H., Marchal S., D'Hallewin M.A., Guillemin F., and Bezdetnaya L. Primary photodamage sites and mitochondrial events after Foscan photosensitization of MCF-7 human breast cancer cells. Photochem. Photobiol. 78 (2003) 9-14
29. Fabris C., Valduga G., Miotto G., Borsetto L., Jori G., Garbisa S., and Reddi E. Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis. Cancer Res. 61 (2001) 7495-7500
30. Kessel D., and Luo Y. Intracellular sites of photodamage as a factor in apoptotic cell death. J. Porphy. Phthalocya. 5 (2001) 181-184
31. Kessel D., Luo Y., Deng Y., and Chang C.K. The role of subcellular localization in initiation of apoptosis by photodynamic therapy. Photochem. Photobiol. 65 (1997) 422-426